Drug Shortage Report for DEXTROSE INJECTION

Last updated on 2025-05-02 History
Report ID 254610
Drug Identification Number 02517132
Brand name DEXTROSE INJECTION
Common or Proper name DEXTROSE INJECTION USP
Company Name OMEGA LABORATORIES LIMITED
Market Status MARKETED
Active Ingredient(s) DEXTROSE
Strength(s) 50%
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS
Packaging size 10 x 50mL vial / fiole
ATC code B05BA
ATC description I.V. SOLUTIONS
Reason for shortage Requirements related to complying with good manufacturing practices.
Anticipated start date
Actual start date 2025-04-30
Estimated end date 2025-08-31
Actual end date
Shortage status Actual shortage
Updated date 2025-05-02
Company comments Some product available at CPDN.
Health Canada comments
Tier 3 Status No
Contact Address 11177 HAMON
MONTREAL, QUEBEC
CANADA H3M 3E4
Company contact information info@omegalaboratory.com - 1-800-363-0584

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v7 2025-05-02 French Compare
v6 2025-05-02 English Compare
v5 2025-05-02 French Compare
v4 2025-05-02 English Compare
v3 2025-04-15 English Compare
v2 2025-04-08 French Compare
v1 2025-04-08 English Compare

Showing 1 to 7 of 7